ACTB and central nervous system cancer: DPYL2, which is a promoter of microtubule assembly, shows increased expression levels in GBM, being recognized as a “glioma reference biomarker” together with ACTB and other proteins [71], the overexpression of which is currently under intense investigation for their involvement in tumor cell migration and metastasis, mainly in glioma [72].